Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Valeo Pharmainc (VPH.TO)

Valeo Pharmainc (VPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,440
  • Shares Outstanding, K 98,657
  • Annual Sales, $ 53,910 K
  • Annual Income, $ -27,808 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.30
  • Price/Sales 0.07
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.08 on 09/12/24
  • Next Earnings Date 09/11/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 +12.50%
on 09/30/24
0.0750 -40.00%
on 09/12/24
-0.0200 (-30.77%)
since 08/30/24
3-Month
0.0400 +12.50%
on 09/30/24
0.1150 -60.87%
on 07/18/24
-0.0600 (-57.14%)
since 06/28/24
52-Week
0.0400 +12.50%
on 09/30/24
0.3850 -88.31%
on 01/18/24
-0.1800 (-80.00%)
since 09/29/23

Most Recent Stories

More News
VALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS UNDER THE CCAA TO IMPLEMENT A REVIEW OF ITS STRATEGIC ALTERNATIVES

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (FSE: VP2), a Canadian pharmaceutical company, announced today that the Québec Superior Court (Commercial Division) (the...

VPH.TO : 0.0450 (unch)
VALEO PHARMA REPORTS THIRD QUARTER 2024 REVENUES

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its financial results for the...

VPH.TO : 0.0450 (unch)
VALEO PHARMA TO HOST THIRD QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it will...

VPHIF : 0.0469 (-50.11%)
VPH.TO : 0.0450 (unch)
Stocks in play: Valeo Pharma Inc.

Announced that it has entered into an agreement with Sagard Healthcare Royalty Partners, LP, which amends ...

VPH.TO : 0.0450 (unch)
VALEO PHARMA AMENDS CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that it has entered into an...

VPH.TO : 0.0450 (unch)
Stocks in play: Valeo Pharma Inc.

Is voluntarily delisting its Class A shares from trading on the OTCQB Venture Market due to low trading ...

VPH.TO : 0.0450 (unch)
VALEO PHARMA ANNOUNCES VOLUNTARY DELISTING FROM OTCQB VENTURE MARKET

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that the Company...

VPHIF : 0.0469 (-50.11%)
VPH.TO : 0.0450 (unch)
VALEO PHARMA ANNOUNCES LEADERSHIP CHANGES

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that the...

VPHIF : 0.0469 (-50.11%)
VPH.TO : 0.0450 (unch)
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Mr. Al...

AGN.AX : 0.750 (-1.32%)
VPHIF : 0.0469 (-50.11%)
VPH.TO : 0.0450 (unch)
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its financial...

VPH.TO : 0.0450 (unch)
VPHIF : 0.0469 (-50.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy,...

See More

Key Turning Points

3rd Resistance Point 0.0450
2nd Resistance Point 0.0450
1st Resistance Point 0.0450
Last Price 0.0450
1st Support Level 0.0450
2nd Support Level 0.0450
3rd Support Level 0.0450

See More

52-Week High 0.3850
Fibonacci 61.8% 0.2532
Fibonacci 50% 0.2125
Fibonacci 38.2% 0.1718
Last Price 0.0450
52-Week Low 0.0400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar